Efficacy and immunogenicity of R21/Matrix-M vaccine against clinical malaria after 2 years' follow-up in children in Burkina Faso: a phase 1/2b randomised controlled trialMehreen S. Datoo, Halidou Tinto, Toussaint Rouamba et al.|The Lancet Infectious Diseases|2022Cited by 285
Plasmodium falciparum sexual conversion rates can be affected by artemisinin-based treatment in naturally infected malaria patientsHarvie P. Portugaliza, Anna Rosanas‐Urgell, Hamtandi Magloire Natama et al.|EBioMedicine|2022Cited by 15